Stock Events

Stock Events

CANCER CAPITAL CORP 

$0.000000
8
+$0.00+0% Monday 00:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-38,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences is a biopharmaceutical company that develops and markets treatments for cancer, posing competition in the oncology drug market.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb is a global biopharmaceutical company with a strong portfolio of cancer treatments, competing in the same therapeutic area.
Merck
MRK
Mkt Cap370.89B
Merck & Co., Inc. offers a range of cancer treatments, including immunotherapies, directly competing with Cancer Capital's focus area.
Pfizer
PFE
Mkt Cap162.16B
Pfizer has a diversified portfolio that includes oncology drugs, making it a competitor in the cancer treatment market.
AMGEN
AMGN
Mkt Cap236.38B
Amgen focuses on human therapeutics, including oncology, competing in the development and commercialization of cancer treatments.
Novartis
NVS
Mkt Cap304.1B
Novartis AG, with its strong emphasis on research and development in oncology, competes in the global market for cancer treatments.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a major player in the oncology market, with a wide range of cancer drugs, competing in both innovation and market share.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC has a significant focus on oncology, with a pipeline of cancer treatments that compete with Cancer Capital's interests.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.22B
Regeneron Pharmaceuticals, known for its innovative biotechnology, competes in the oncology space with treatments for various cancers.

About

Show more...
CEO
Country
United States

Listings

0 Comments

Share your thoughts

FAQ

What is CANCER CAPITAL CORP stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange CANCER CAPITAL CORP stocks are traded under the ticker CNCL.
What is CANCER CAPITAL CORP revenue for the last year?▼
CANCER CAPITAL CORP revenue for the last year amounts to 0 USD.
What is CANCER CAPITAL CORP net income for the last year?▼
CNCL net income for the last year is -38,000 USD.
In which sector is CANCER CAPITAL CORP located?▼
CANCER CAPITAL CORP operates in the Other sector.
When did CANCER CAPITAL CORP complete a stock split?▼
CANCER CAPITAL CORP has not had any recent stock splits.